Vaishali Pharma Ltd announced a 1:1 bonus issue and a 1:5 stock split to reward shareholders and enhance liquidity, expecting to boost annual revenue by Rs. 100 million from new registrations in global markets, with Q1FY25 sales rising 34.70% to Rs. 18.08 crore and net profit increasing by 7.13%.